These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 30068426

  • 1. Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised.
    Gustafsson HC, Goodman SH, Feng T, Choi J, Lee S, Newport DJ, Knight B, Pingeton B, Stowe ZN, Monk C.
    Dev Psychopathol; 2018 Aug; 30(3):773-785. PubMed ID: 30068426
    [Abstract] [Full Text] [Related]

  • 2. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL, O'Grady KE, Battle CL, Wisner KL, Anderson GM, Stroud LR, Miller-Loncar CL, Young ME, Lester BM.
    Am J Psychiatry; 2016 Feb 01; 173(2):147-57. PubMed ID: 26514656
    [Abstract] [Full Text] [Related]

  • 3. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
    Santucci AK, Singer LT, Wisniewski SR, Luther JF, Eng HF, Dills JL, Sit DK, Hanusa BH, Wisner KL.
    J Clin Psychiatry; 2014 Oct 01; 75(10):1088-95. PubMed ID: 25373117
    [Abstract] [Full Text] [Related]

  • 4. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC.
    Psychopharmacology (Berl); 2011 Sep 01; 217(2):211-9. PubMed ID: 21499702
    [Abstract] [Full Text] [Related]

  • 5. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C, Cha J, Hong S, Bastidas V, Weissman M, Fifer WP, Myers M, Talati A, Bansal R, Peterson BS, Monk C, Gingrich JA, Posner J.
    JAMA Pediatr; 2018 Jun 01; 172(6):525-533. PubMed ID: 29630692
    [Abstract] [Full Text] [Related]

  • 6. The effect of perinatal exposures on the infant: antidepressants and depression.
    Hanley GE, Oberlander TF.
    Best Pract Res Clin Obstet Gynaecol; 2014 Jan 01; 28(1):37-48. PubMed ID: 24100223
    [Abstract] [Full Text] [Related]

  • 7. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
    Salisbury AL, Wisner KL, Pearlstein T, Battle CL, Stroud L, Lester BM.
    Depress Anxiety; 2011 Nov 01; 28(11):1008-19. PubMed ID: 21898709
    [Abstract] [Full Text] [Related]

  • 8. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov 01; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

  • 9. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D, Brownell M, Chateau D, Ruth C, Katz LY.
    BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401
    [Abstract] [Full Text] [Related]

  • 10. Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI).
    Malm H, Artama M, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague I, Sourander A.
    BMC Psychiatry; 2012 Dec 04; 12():217. PubMed ID: 23206294
    [Abstract] [Full Text] [Related]

  • 11. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.
    Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE.
    J Pediatr; 2003 Apr 04; 142(4):402-8. PubMed ID: 12712058
    [Abstract] [Full Text] [Related]

  • 12. SSRI treatment during pregnancy: are we asking the right questions?
    Wisner KL.
    Depress Anxiety; 2010 Aug 04; 27(8):695-8. PubMed ID: 20694964
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.
    J Clin Psychiatry; 2004 Feb 04; 65(2):230-7. PubMed ID: 15003078
    [Abstract] [Full Text] [Related]

  • 14. Fine Motor Differences and Prenatal Serotonin Reuptake Inhibitors Exposure.
    Partridge MC, Salisbury AL, LaGasse LL.
    J Pediatr; 2016 Aug 04; 175():144-149.e1. PubMed ID: 27215778
    [Abstract] [Full Text] [Related]

  • 15. Mothers, Babies, Depression, and Medications: Understanding the Complex Interplay of Illness and Treatment on Neonatal Symptoms.
    Chaudron LH.
    Am J Psychiatry; 2016 Feb 01; 173(2):101-2. PubMed ID: 26844789
    [No Abstract] [Full Text] [Related]

  • 16. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
    Grzeskowiak LE, Gilbert AL, Sørensen TI, Olsen J, Sørensen HT, Pedersen LH, Morrison JL.
    Ann Epidemiol; 2013 Nov 01; 23(11):681-7. PubMed ID: 24113367
    [Abstract] [Full Text] [Related]

  • 17. In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners.
    Singal D, Chateau D, Struck S, Lee JB, Dahl M, Derksen S, Katz LY, Ruth C, Hanlon-Dearman A, Brownell M.
    Pediatrics; 2020 May 01; 145(5):. PubMed ID: 32341177
    [Abstract] [Full Text] [Related]

  • 18. Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.
    Gur TL, Kim DR, Epperson CN.
    Psychopharmacology (Berl); 2013 Jun 01; 227(4):567-82. PubMed ID: 23681158
    [Abstract] [Full Text] [Related]

  • 19. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications.
    Misri S, Reebye P, Kendrick K, Carter D, Ryan D, Grunau RE, Oberlander TF.
    Am J Psychiatry; 2006 Jun 01; 163(6):1026-32. PubMed ID: 16741203
    [Abstract] [Full Text] [Related]

  • 20. One-Year Developmental Outcomes for Infants of Mothers With Bipolar Disorder.
    Santucci AK, Singer LT, Wisniewski SR, Luther JF, Eng HF, Sit DK, Wisner KL.
    J Clin Psychiatry; 2017 Jun 01; 78(8):1083-1090. PubMed ID: 28068465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.